Email Updates

You are here

Trial Summary Table

Trial Name Phase Start Date Sponsors Countries Population Candidate(s) Status Expected Completion Date
HHR Study Other Monday, January 31, 2011 New York University, NIDA Women, Men, HIV positive Ongoing December 2016
HOME: a comprehensive HIV testing and linkage package for young MSM of color Other Tuesday, January 31, 2012 NIH, Public Health Foundation Enterprises United States of America MSM Planned December 2017
HPTN 052 III Tuesday, February 1, 2005 HPTN, NIAID United States of America, Botswana, Brazil, India, Kenya, Malawi, South Africa, Thailand, Zimbabwe Women, Men Atazanavir, Didanosine, Efavirenz, Lamivudine, Lopinavir/Ritonavir, Nevirapine, Stavudine, TDF, TDF/FTC (Truvada), Zidovudine/Lamivudine Completed May 2015
HPTN 065 (TLC-Plus) Other Thursday, September 30, 2010 HIV Prevention Trials Network & NIAID United States of America Women, Men, HIV positive Completed December 2014
HPTN 071 (PopART) Open Label Saturday, August 31, 2013 NIAID, NIMH, NIDA, Office of the U.S. Global AIDS Coordinator, Bill & Melinda Gates Foundation, & NIH South Africa, Zambia Women, Men, HIV positive Completed August 2017
HPTN 074 Open Label, III Sunday, February 1, 2015 HPTN, NIDA, NIAID Indonesia, Ukraine, Thailand HIV positive, Injecting drug users Completed June 2018
HPTN 078 Other Monday, June 6, 2016 NIAID (DAIDS ID: 11995) United States of America HIV positive, MSM Completed February 2019
HPTN 094/ INTEGRA Demo Project, Open Label Wednesday, June 9, 2021 NIAID (DAIDS ID: 38715) United States of America HIV positive, Injecting drug users, Men, Women Ongoing
HPTN 096 Open Label, Other Friday, April 1, 2022 HPTN; DIAID, NAID HIV positive, MSM Ongoing June 2027
imPACT Other Saturday, March 31, 2012 University of North Carolina - Chapel Hill, NIH, NIDA United States of America Women, Men, HIV positive Ongoing October 2014